Nolotil painkiller, banned in UK, but prescribed in Spain 'is killing Brits' claim

SPAINKILLERS: Urgent new research is needed on genetic differences. SPAINKILLERS: Urgent new research is needed on genetic differences. @hm7madq/Twitter

RESEARCH has shown that at least ten Britons have died after taking one of Spain’s most popular painkillers, Nolotil, which is banned in the UK.

In addition, more than 100 British and Irish expatriates and tourists in Spain have suffered devastating side effects after taking the drug.

The medicines regulator in Spain confirmed yesterday (Saturday) that it had launched an investigation into concerns that northern Europeans may be more at risk of side effects from Nolotil.

The painkiller has not been licensed in many countries, including the United States, Britain and Sweden, because of a possible side effect which can lead to blood poisoning and death.

Dr Rashmi Shah, a former senior clinical assessor at the Medicines and Healthcare Products Regulatory Agency, London, said: “We have known for a long time that because of genetic differences people from particular ethnic groups can have higher probability of risk or benefit from certain medicines.

The regulators, therefore, require analysis of safety and efficacy data by population, gender and age.”

The Spanish Agency of Medicines and Medical Devices said it was gathering more evidence on the cases.

Boehringer Ingelheim, the manufacturer of Nolotil, responded in a statement:

“We take very seriously every case where a patient suffers an adverse event.

“Nolotil must not be given without a prescription. There is no scientific evidence on specific populations that are prone to develop any side effects.”

Comments (0)

There are no comments posted here yet

Leave your comments

Posting comment as a guest.
0 Characters
Attachments (0 / 3)
Share Your Location

Poll of the Week

Do you think it’s important to speak Spanish, living or holidaying in Spain?

New online edition graphic

Create Spain Alert

Do you want to be the first to receive our latest news from Spain? Subscribe here.